tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2021 Jul 20;8(8)
fab369.
doi: 10.1093/ofid/ofab369. eCollection 2021 Aug.
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual
Solen Kernéis[SUP] 1 2 [/SUP], Delphine Planas[SUP] 3 4 [/SUP], Sandrine Imbeaud[SUP] 5 [/SUP], Isabelle Staropoli[SUP] 3 4 [/SUP], Julien Puech[SUP] 6 [/SUP], Nicolas Robillard[SUP] 6 [/SUP], Julien Rodary[SUP] 6 [/SUP], Timothée Bruel[SUP] 3 4 [/SUP], Thomas Vieillard[SUP] 7 [/SUP], Olivier Schwartz[SUP] 3 4 [/SUP], Laurent Belec[SUP] 6 8 9 [/SUP], Hélène Péré[SUP] 5 [/SUP], David Veyer[SUP] 5 6 [/SUP]
Affiliations
Abstract
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.
Keywords: BNT162b2; SARS-CoV-2; transmission; vaccination.
. 2021 Jul 20;8(8)
doi: 10.1093/ofid/ofab369. eCollection 2021 Aug.
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual
Solen Kernéis[SUP] 1 2 [/SUP], Delphine Planas[SUP] 3 4 [/SUP], Sandrine Imbeaud[SUP] 5 [/SUP], Isabelle Staropoli[SUP] 3 4 [/SUP], Julien Puech[SUP] 6 [/SUP], Nicolas Robillard[SUP] 6 [/SUP], Julien Rodary[SUP] 6 [/SUP], Timothée Bruel[SUP] 3 4 [/SUP], Thomas Vieillard[SUP] 7 [/SUP], Olivier Schwartz[SUP] 3 4 [/SUP], Laurent Belec[SUP] 6 8 9 [/SUP], Hélène Péré[SUP] 5 [/SUP], David Veyer[SUP] 5 6 [/SUP]
Affiliations
- PMID: 34377731
- PMCID: PMC8339281
- DOI: 10.1093/ofid/ofab369
Abstract
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.
Keywords: BNT162b2; SARS-CoV-2; transmission; vaccination.